Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease

Journal of Experimental Medicine

Volumn 211, Issue 9, 2014, Pages 1847-1856

  Kurnellas, Michael P ^a   Schartner, Jill M ^a   Fathman, C Garrison ^a   Jagger, Ann ^a   Steinman, Lawrence ^a   Rothbard, Jonathan B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GAMMA INTERFERON; HEXAPEPTIDE; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; ENDOCYTOSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FIBER; GENE EXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ADULT; AMYLOID; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE I; INTERFERON-GAMMA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; TAU PROTEINS; TH1 CELLS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906534097     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20140107     Document Type: Article

References (35)

1. Arnason, B.G.W. 1999. Immunologic therapy of multiple sclerosis. Annu. Rev. Med. 50:291-302. http://dx.doi.org/10.1146/annurev.med.50.1.291
2. Axtell, R.C., and C. Raman. 2012. Janus-like effects of type I interferon in autoimmune diseases. Immunol. Rev. 248:23-35. http://dx.doi.org/10.1111/j.1600-065X.2012.01131.x
3. Axtell, R.C., B.A. de Jong, K. Boniface, L.F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J.G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16:406-412. http://dx.doi.org/10.1038/nm.2110
4. Axtell, R.C., C. Raman, and L. Steinman. 2011. Interferon-β exacerbates Th17-mediated inflammatory disease. Trends Immunol. 32:272-277. http://dx.doi.org/10.1016/j.it.2011.03.008
5. Axtell, R.C., C. Raman, and L. Steinman. 2013. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin. Rev. Allergy Immunol. 44:114-120. http://dx.doi.org/10.1007/s12016-011-8296-5
6. Azevedo, E.P., A.B. Guimarães-Costa, G.S. Torezani, C.A. Braga, F.L. Palhano, J.W. Kelly, E.M. Saraiva, and D. Foguel. 2012. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase. J. Biol. Chem. 287:37206-37218. http://dx.doi.org/10.1074/jbc. M112.369942
7. Calero, M., A. Rostagno, and J. Ghiso. 2012. Search for amyloid-binding proteins by affinity chromatography. Methods Mol. Biol. 849:213-223. http://dx.doi.org/10.1007/978-1-61779-551-0_15
8. Di Domizio, J., R. Zhang, L.J. Stagg, M. Gagea, M. Zhuo, J.E. Ladbury, and W. Cao. 2012. Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid. J. Biol. Chem. 287:736-747. http://dx.doi.org/10.1074/jbc. M111.238477
9. Doherty, G.J., and H.T. McMahon. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78:857-902. http://dx.doi.org/10.1146/annurev.biochem.78.081307.110540
10. Eisenberg, D., and M. Jucker. 2012. The amyloid state of proteins in human diseases. Cell. 148:1188-1203. http://dx.doi.org/10.1016/j.cell.2012.02.022
11. Erlich, P., C. Dumestre-Pérard, W.L. Ling, C. Lemaire-Vieille, G. Schoehn, G.J. Arlaud, N.M. Thielens, J. Gagnon, and J.Y. Cesbron. 2010. Complement protein C1q forms a complex with cytotoxic prion protein oligomers. J. Biol. Chem. 285:19267-19276. http://dx.doi.org/10.1074/jbc. M109.071860
12. Goldschmidt, L., P.K. Teng, R. Riek, and D. Eisenberg. 2010. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. USA. 107:3487-3492. http://dx.doi.org/10.1073/pnas.0915166107
13. Gourdain, P., C. Ballerini, A.B. Nicot, and C. Carnaud. 2012. Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system. J. Neuroinflammation. 9:25. http://dx.doi.org/10.1186/1742-2094-9-25
14. Grant, J.L., E.E. Ghosn, R.C. Axtell, K. Herges, H.F. Kuipers, N.S. Woodling, K. Andreasson, L.A. Herzenberg, L.A. Herzenberg, and L. Steinman. 2012. Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci. Transl. Med. 4:145ra105. http://dx.doi.org/10.1126/scitranslmed.3004145
15. Hahm, B., M.J. Trifilo, E.I. Zuniga, and M.B. Oldstone. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity. 22:247-257. http://dx.doi.org/10.1016/j.immuni.2005.01.005
16. Hong, D.P., and A.L. Fink. 2005. Independent heterologous fibrillation of insulin and its B-chain peptide. Biochemistry. 44:16701-16709. http://dx.doi.org/10.1021/bi051658y
17. Hong, D.P., A. Ahmad, and A.L. Fink. 2006. Fibrillation of human insulin A and B chains. Biochemistry. 45:9342-9353. http://dx.doi.org/10.1021/bi0604936
18. Ji, Z., Z.J. Ke, and J.G. Geng. 2012. SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol. Cell Biol. 90:388-395. http://dx.doi.org/10.1038/icb.2011.51
19. Kurnellas, M.P., C.M. Adams, R.A. Sobel, L. Steinman, and J.B. Rothbard. 2013. Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci. Transl. Med. 5:179ra42. http://dx.doi.org/10.1126/scitranslmed.3005681
20. Lande, R., D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, J. Gregorio, S. Meller, G. Chamilos, R. Sebasigari, V. Riccieri, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3:73ra19. http://dx.doi.org/10.1126/scitranslmed.3001180
21. López De La Paz, M., K. Goldie, J. Zurdo, E. Lacroix, C.M. Dobson, A. Hoenger, and L. Serrano. 2002. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. USA. 99:16052-16057. http://dx.doi.org/10.1073/pnas.252340199
22. Matsubara, E., C. Soto, S. Governale, B. Frangione, and J. Ghiso. 1996. Apolipoprotein J and Alzheimer's amyloid beta solubility. Biochem. J. 316:671-679.
23. Narayan, P., S. Meehan, J.A. Carver, M.R. Wilson, C.M. Dobson, and D. Klenerman. 2012. Amyloid-β oligomers are sequestered by both intracellular and extracellular chaperones. Biochemistry. 51:9270-9276. http://dx.doi.org/10.1021/bi301277k
24. Nelson, R., M.R. Sawaya, M. Balbirnie, A.O. Madsen, C. Riekel, R. Grothe, and D. Eisenberg. 2005. Structure of the cross-β spine of amyloid-like fibrils. Nature. 435:773-778. http://dx.doi.org/10.1038/nature03680
25. Ousman, S.S., B.H. Tomooka, J.M. van Noort, E.F. Wawrousek, K.C. O'Connor, D.A. Hafler, R.A. Sobel, W.H. Robinson, and L. Steinman. 2007. Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature. 448:474-479. http://dx.doi.org/10.1038/nature05935
26. Sawaya, M.R., S. Sambashivan, R. Nelson, M.I. Ivanova, S.A. Sievers, M.I. Apostol, M.J. Thompson, M. Balbirnie, J.J. Wiltzius, H.T. McFarlane, et al. 2007. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature. 447:453-457. http://dx.doi.org/10.1038/nature05695
27. Scott, G.S., S.V. Spitsin, R.B. Kean, T. Mikheeva, H. Koprowski, and D.C. Hooper. 2002. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc. Natl. Acad. Sci. USA. 99:16303-16308. http://dx.doi.org/10.1073/pnas.212645999
28. Serada, S., M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi, S. Nomura, H. Yoshida, T. Nishikawa, F. Terabe, T. Ohkawara, et al. 2008. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 105:9041-9046. http://dx.doi.org/10.1073/pnas.0802218105
29. Sheedy, F.J., A. Grebe, K.J. Rayner, P. Kalantari, B. Ramkhelawon, S.B. Carpenter, C.E. Becker, H.N. Ediriweera, A.E. Mullick, D.T. Golenbock, et al. 2013. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14:812-820. http://dx.doi.org/10.1038/ni.2639
30. Sjöberg, A.P., S. Nyström, P. Hammarström, and A.M. Blom. 2008. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. Mol. Immunol. 45:3213-3221. http://dx.doi.org/10.1016/j.molimm.2008.02.023
31. Sjölander, J., G.T. Westermark, E. Renström, and A.M. Blom. 2012. Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation. J. Biol. Chem. 287:10824-10833. http://dx.doi.org/10.1074/jbc. M111.244285
32. Sokolowski, J.D., and J.W. Mandell. 2011. Phagocytic clearance in neurodegeneration. Am. J. Pathol. 178:1416-1428. http://dx.doi.org/10.1016/j.ajpath.2010.12.051
33. Weinger, J.G., P. Davies, C.M. Acker, C.F. Brosnan, V. Tsiperson, A. Bayewitz, and B. Shafit-Zagardo. 2012. Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Neuropathol. Exp. Neurol. 71:422-433. http://dx.doi.org/10.1097/NEN.0b013e3182540d2e
34. Wender, P.A., D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard. 2000. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA. 97:13003-13008. http://dx.doi.org/10.1073/pnas.97.24.13003
35. Wiltzius, J.J., S.A. Sievers, M.R. Sawaya, D. Cascio, D. Popov, C. Riekel, and D. Eisenberg. 2008. Atomic structure of the cross-β spine of islet amyloid polypeptide (amylin). Protein Sci. 17:1467-1474. http://dx.doi.org/10.1110/ps.036509.108